2009
DOI: 10.1111/j.1524-4733.2009.00622.x
|View full text |Cite
|
Sign up to set email alerts
|

Evidence-Based Decision on Medical Technologies in Asia Pacific: Experiences from India, Malaysia, Philippines, and Pakistan

Abstract: In the region under discussion, one of the priority areas that the different regulatory agencies would benefit from is human resource development to facilitate the process of evidence based assessment of health technologies. Higher budgetary allocation and stronger legislation is also needed along with interagency and international coordination and cooperation to harmonize.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
37
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(37 citation statements)
references
References 2 publications
0
37
0
Order By: Relevance
“…In Askes scheme, a fixed amount is reimbursed, and an annual reimbursement list is published [36] . Philippines publishes Philippine National Drug Formulary (PNDF), the drugs listed on which are reimbursed [33] and has also adopted pharmacoeconomic and cost-effectiveness approach to take decision on reimbursement of non-PNDF drugs [33] . Further, setting a maximum reimbursable amount is practiced for in-patient medicines; out-patient ones have to be borne by the person out of pocket [21,33] .…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…In Askes scheme, a fixed amount is reimbursed, and an annual reimbursement list is published [36] . Philippines publishes Philippine National Drug Formulary (PNDF), the drugs listed on which are reimbursed [33] and has also adopted pharmacoeconomic and cost-effectiveness approach to take decision on reimbursement of non-PNDF drugs [33] . Further, setting a maximum reimbursable amount is practiced for in-patient medicines; out-patient ones have to be borne by the person out of pocket [21,33] .…”
Section: Resultsmentioning
confidence: 99%
“…Thailand, Malaysia, Indonesia, Philippines and Cambodia have been proposed, although this has yet to be put into practice [15] . Philippines has in place drugs price monitoring, with monthly data collection of drug prices and annual comparison with international price [33] . Further, prices for 185 drugs have been published, termed as Drug Price Reference Index (DPRI), which help maintain price transparency and work as ceiling prices for reimbursement [33] .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations